SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
4624Visicu: Great Promise, But Beware Scott Reeves, 03.31.06, 6:00 AM ET New York -dr.praveen4/4/2006
46233/31/2006 ACHN Drug developer Achillion files for IPO Achillion, a developer ofsjemmeri4/3/2006
46223/31/2006 PTCT Biotech PTC Therapeutics files for IPO PTC Therapeutics, a develsjemmeri4/3/2006
4621(RMTI) Rockwell Medical is beginning to pick up interest, as investors have takeRRICH44/2/2006
4620United States: Life Sciences: 2005 Trends in Partnering and Collaborations 29 Msim13/31/2006
4619Amylin Pharmaceuticals Announces Public Offering of Common Stock Thursday March nigel bates3/30/2006
4618Keryx Biopharmaceuticals to Raise $82 Million in Registered Direct Offering of Cnigel bates3/27/2006
46173/24/2006 OMRI Biotech Omrix sets terms Omrix Biopharmaceuticals, a developer ofsjemmeri3/26/2006
4616crxx issues: Message 22287342mopgcw3/23/2006
4615Making Space for a Biotech Center [NYT] By ROBERT SHAROFF Published: March 22,Doc Bones3/22/2006
4614BioMarin Announces Proposed Concurrent Public Offerings of Common Stock and Seninigel bates3/20/2006
46133/16/2006 TRGT Drug developer Targacept sets terms Targacept, a developer of a sjemmeri3/17/2006
4612Sunesis Pharmaceuticals Announces $45 Million Private Placement Friday March 17,nigel bates3/17/2006
4611Biomedical Entrepreneur Working On Plan To Translate Basic Research Into Productsjemmeri3/15/2006
4610Don't think so. Time to buy was a year ago - uk.finance.yahoo.com (Not thatnigel bates3/14/2006
4609"Expect a higher bid from the NYSE ?" Apparently everyone does, and tJohn Metcalf3/13/2006
4608Actually, they have a point. The strategic value of the LSE probably well exceednigel bates3/11/2006
4607"substantially undervalues the company, its unique position and the very siJohn Metcalf3/10/2006
4606<i>Many European companies have scrapped U.S. listings..</i> LONDONnigel bates3/10/2006
4605Dyax Corp. Announces Public Offering of Common Stock Wednesday March 8, 4:40 pm nigel bates3/8/2006
46043/8/2006 ALXA Alexza Pharmaceuticals prices below range at $8 Alexza Pharmaceutsjemmeri3/8/2006
4603Medical-Device Firms Receive A Healthy Increase in Funding [WSJ] By PETER LOFTUDoc Bones3/8/2006
4602Favrille Announces $45 Million Financing to Support Clinical Development and Comnigel bates3/7/2006
4601BVF Update; dumped a few major positions; established some new ones notably admopgcw3/6/2006
4600Novartis to Pay Infinity to Develop Cancer Treatments [WSJ] By ROBERT TOMSHO MaDoc Bones3/6/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News